Alvotech and dr. reddy's announce fda acceptance of biologic license application for avt03, a proposed biosimilar to prolia® and xgeva®

Hyderabad, india & reykjavik, iceland--(business wire)---- $rdy #avt03--alvotech and dr. reddy's announce fda acceptance of biologic license application for avt03, a proposed biosimilar to prolia® and xgeva®.

ALVO Ratings Summary

ALVO Quant Ranking